Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03060863 · ClinicalTrials.gov registry record · NA
ABC Brain Games Self-Regulation Intervention
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 246
- Enrollment target
NCT03060863: Completed NA study, sponsored by University of Michigan.
NCT03060863 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 246 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03060863, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 246 participants
- Enrollment target
Study Summary
The goal of this project is to measure childhood self-regulation targets known to be associated with obesity risk and poor adherence to medical regimens and to assess whether intervening on these mechanisms can improve self-regulation. The investigators will do so in a pre-existing cohort of low-income school-age children.
Primary Outcome
Working memory is assessed using a standardized digit span task from the Wechsler Intelligence Scale for Children-WISC-IV, which requires participants to recite digits they have just heard in progressively longer sequences. The longest correct span of digits the participants repeats is the index of working memory.
Interventions
- BEHAVIORAL 2. Executive Functioning
- BEHAVIORAL 3. Food Bias
- BEHAVIORAL 4. Emotion Regulation
- BEHAVIORAL 5. Future orientation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2018-01-31 |
| Phase | NA |
What the finished NCT03060863 record still lists
NCT03060863 is an interventional study that assigns participants to a tested intervention. The registered 246 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 4 interventions - of which 2. Executive Functioning is the first listed.
NCT03060863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03060863 about?
NCT03060863 is a clinical study titled "ABC Brain Games Self-Regulation Intervention". The goal of this project is to measure childhood self-regulation targets known to be associated with obesity risk and poor adherence to medical regimens and to assess whether intervening on these mechanisms can improve self-regulation. The investigators will do so in a pre-existing cohort of low-inc...
What is the current status of trial NCT03060863?
This trial is currently completed. It is a NA study. The enrollment target is 246 participants. The study started on 2015-09-01. Estimated completion is 2018-01-31.
What interventions are being tested in trial NCT03060863?
The interventions under investigation include: 2. Executive Functioning (BEHAVIORAL), 3. Food Bias (BEHAVIORAL), 4. Emotion Regulation (BEHAVIORAL), 5. Future orientation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03060863?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03060863's enrollment target sits among peer trials
246 436th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04973605 · 246 participants · Phase 1
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- NCT06395168 · 246 participants · NA
Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination
- NCT07048769 · 246 participants · Phase 4
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
- NCT07176650 · 246 participants · Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI